Heart and Vascular
ARTEMIS
Cardiopulmonary Bypass
ARTEMIS: RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study
Contact Research Team:
[email protected]
Site principal investigator:
Sean McCarney, MD
Learn more about this study:
NCT05746559